FTC 200mg+TDF 300mg tabs/PAC-30

NOTE: The description below is for a standard product. It is notspecific to patent status and pricing policies that may apply at countrylevel. This information is available on request from Supply Division:Contact: supply@unicef.org

General Description:
Emtricitabine 200mg + Tenofovir 300mg Tablets, pack of 30

Technical Specifications:
Each film coated tablet contains Emtricitabine 200mg and TenofovirDisoproxil Fumarate 300mg which is equivalent to 245mg of TenofovirDisoproxil as fixed dose combination (FDC).

Therapeutic class:
Emtricitabine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Standard shelf life:
2 years (24 months)

Other available formulations:
The product may also be available in other formulations, pack sizes, orin combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines

and

WHO EssentialMedicines Library

or your regional national guidelines

For details about paediatric dosage schemes, please click the linkslisted below:

WHO HIV/AIDS

WHO Generic tool for assessing paediatric ARV dosing

Indications:
Management of HIV-1 infection in adults in combination with at least oneother antiretroviral drug. By mouth (oral), PO

Storage:
Do not store above 30ºC (86ºF).
Store in a tightly closed container.
Keep out of reach and sight of children.